AbbVie's global products, such as Rinvoq, have different approved uses and marketing guidelines in the US versus the European Union. This creates a significant operational and compliance challenge, requiring sophisticated systems to manage regulatory affairs, marketing content, and commercial strategies on a per-region basis.
Filing excerpt
In the United States, Rinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis... In the European Union, Rinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis... in adult patients who have an inadequate response or intolerance to disease-modifying anti-rheumatic medicines (DMARDs).
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10kcomplianceBurdenGet every 10-K signal for AbbVie and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/55f37fb9-b91d-4f09-bcb9-b3f2a4b3adad returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.
{
"signal_id": "55f37fb9-b91d-4f09-bcb9-b3f2a4b3adad",
"signal_type": "sec-10k",
"signal_subtype": "complianceBurden",
"detected_at": "2026-02-24T09:18:27.385+00:00",
"company": {
"name": "AbbVie",
"domain": "abbvie.com"
},
"data": {
"detail": "AbbVie's global products, such as Rinvoq, have different approved uses and marketing guidelines in the US versus the European Union. This creates a significant operational and compliance challenge, requiring sophisticated systems to manage regulatory affairs, marketing content, and commercial strategies on a per-region basis.",
"summary": "High compliance burden from managing different drug indications across US, EU, and Japan.",
"excerpts": "In the United States, Rinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis... In the European Union, Rinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis... in adult patients who have an inadequate response or intolerance to disease-modifying anti-rheumatic medicines (DMARDs).",
"relevance": 0.8,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/abbv-20251231.htm",
"filing_date": "2026-02-20",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "GRC tools needed",
"signal_category": "risk",
"regions_mentioned": [
"United States",
"European Union",
"Japan",
"North America",
"Canada"
]
}
}
curl https://signals.autobound.ai/v1/signals/55f37fb9-b91d-4f09-bcb9-b3f2a4b3adad \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbvie.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.